JACOB GARY S

CIK 00012668026 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001266802

Recent Transactions

50 trades

Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2024-02-19+85,000→ 102,120 total
Purchase
OKYO Pharma Ltd$OKYO
American Depositary Shares
2022-05-19$4.00/sh+12,500→ 12,500 total
Award
Virpax Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-01-01+12,091→ 12,091 total
Other
Cardiff Oncology, Inc.$CRDF
Stock Options
2021-06-10+293→ 76,106 total
Other
Cardiff Oncology, Inc.$CRDF
Stock Options
2021-06-10+28,858→ 76,106 total
Other
Cardiff Oncology, Inc.$CRDF
Stock Options
2021-06-10+44,734→ 76,106 total
Other
Cardiff Oncology, Inc.$CRDF
Stock Options
2021-06-10+223→ 76,106 total
Other
Cardiff Oncology, Inc.$CRDF
Stock Options
2021-06-10+223→ 76,106 total
Other
Cardiff Oncology, Inc.$CRDF
Stock Options
2021-06-10+755→ 76,106 total
Other
Cardiff Oncology, Inc.$CRDF
Stock Options
2021-06-10+530→ 76,106 total
Other
Cardiff Oncology, Inc.$CRDF
Stock Options
2021-06-10+218→ 76,106 total
Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2021-05-18+250,000→ 342,785 total
Award
Virpax Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-04-07+13,183→ 13,183 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2021-03-23$10.42/sh+1,900→ 21,452 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2021-03-23$10.39/sh+470→ 21,922 total
Purchase
Virpax Pharmaceuticals, Inc.
Common Stock, $0.00001 par value
2021-02-17$6.79/sh+3,500→ 3,500 total
Purchase
Hepion Pharmaceuticals, Inc.$HEPA
Common Stock
2020-12-01$1.66/sh+12,000→ 12,059 total
Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2020-08-19+30,000→ 92,785 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2020-06-17+28,858→ 76,106 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2020-05-14$1.43/sh+17,483→ 19,552 total
Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2020-04-03+60,000→ 62,729 total
Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2019-07-24+970→ 2,729 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2019-06-20+44,734→ 48,071 total
Purchase
Hepion Pharmaceuticals, Inc.$HEPA
Warrants
2018-07-03$1000.00/sh+8,625→ 8,625 total
Purchase
Hepion Pharmaceuticals, Inc.$HEPA
Series C Convertible Preferred Stock
2018-07-03$1000.00/sh+15→ 15 total
Tax Payment
SYNERGY PHARMACEUTICALS LLC
Common Stock
2018-06-15−131,934→ 745,706 total
Exercise/Conversion
SYNERGY PHARMACEUTICALS LLC
Stock Options
2018-06-15−474,961→ 6,513,342 total
Exercise/Conversion
SYNERGY PHARMACEUTICALS LLC
Common Stock
2018-06-15$0.50/sh+474,961→ 877,640 total
Tax Payment
SYNERGY PHARMACEUTICALS LLC
Common Stock
2018-06-15−150,246→ 595,460 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2018-01-23+54,322→ 248,101 total
Exercise/Conversion
Cardiff Oncology, Inc.$CRDF
Common Stock
2018-01-02+16,667→ 148,954 total
Exercise/Conversion
Cardiff Oncology, Inc.$CRDF
Restricted Stock Units
2018-01-02−16,667→ 0 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2017-10-04+38,106→ 193,779 total
Exercise/Conversion
Cardiff Oncology, Inc.$CRDF
Common Stock
2017-09-02+9,287→ 132,287 total
Exercise/Conversion
Cardiff Oncology, Inc.$CRDF
Restricted Stock Units
2017-09-02−9,287→ 16,667 total
Disposition to Issuer
SYNERGY PHARMACEUTICALS LLC
Stock Options
2017-06-28−900,000→ 5,138,202 total
Award
SYNERGY PHARMACEUTICALS LLC
Stock Options
2017-06-28+900,000→ 6,038,303 total
Purchase
SYNERGY PHARMACEUTICALS LLC
Common Stock
2017-05-26$3.52/sh+5,680→ 402,679 total
Award
Cardiff Oncology, Inc.$CRDF
Restricted Stock Units
2017-01-02+16,667→ 16,667 total
Award
Cardiff Oncology, Inc.$CRDF
Restricted Stock Units
2017-01-02+16,667→ 16,667 total
Award
Cardiff Oncology, Inc.$CRDF
Restricted Stock Units
2017-01-02+9,287→ 25,954 total
Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2016-07-19+65,000→ 1,015,000 total
Award
SYNERGY PHARMACEUTICALS LLC
Stock Options
2016-06-24+970,000→ 5,905,177 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2016-01-04+16,000→ 155,673 total
Award
SYNERGY PHARMACEUTICALS LLC
Stock Options
2015-09-29+500,000→ 4,935,177 total
Award
SYNERGY PHARMACEUTICALS LLC
Stock Options
2015-07-24+300,000→ 4,435,177 total
Exercise/Conversion
SYNERGY PHARMACEUTICALS LLC
Stock Options
2015-07-01−62,965→ 4,135,177 total
Exercise/Conversion
SYNERGY PHARMACEUTICALS LLC
Common Stock
2015-07-01$5.61/sh+62,965→ 396,999 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2015-03-17+16,000→ 139,673 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2014-12-11+15,667→ 123,673 total

Companies

Recent Filings

Address

C/O CALLISTO PHARMACEUTICALS, INC. 420 LEXINGTON AVE., SUITE 1609

NEW YORK, NY, 10170

View on SEC.gov